drugset / Trial / NCT04781959
A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
RandomizedParallel-groupOpen-labelTreatment
Summary
REaCT-5G will compare bone pain from a single dose of Pegfilgrastim to 5 doses of daily filgrastim in breast cancer patients receiving neoadjuvant/adjuvant chemotherapy.
Timeline
- Start
- 2021-06-09
- Primary completion
- 2023-02-23
- Completion
- 2023-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pegfilgrastim | Protein / enzyme biologic | — | Subcutaneous |
| Comparator | filgrastim | Protein / enzyme biologic | — | Subcutaneous |